ReviewImmunotherapy2025
Scalable and cost-effective CAR-T exosome therapies: challenges and future directions.
Xuan Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewImmunotherapy2025
Xuan Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.